NEW ORLEANS – A federal judge has ruled that 1,200 product liability lawsuits filed against the manufacturers of anti-coagulant drug Xarelto will soon be removed from their multi-district litigation (MDL) status, for resolution in separate jury trials.
PHILADELPHIA – Late Tuesday, a state court judge reversed a near-$28 million jury verdict in product liability litigation surrounding the blood thinner Xarelto, a decision that overturned what had been the first win nationally for plaintiffs and included a landmark punitive damages award.
PHILADELPHIA – A cigarette wholesaler in Philadelphia is suing a Delaware retailer for nearly $75,000 related to outstanding costs from a number of sales transactions made between the parties.
PHILADELPHIA – A New Mexico company that provides weight loss and weight maintenance programs alleges that a Glen Mills business failed to deliver the products it ordered.
PHILADELPHIA – The first Pennsylvania state bellwether trial connected to blood thinner drug Xarelto, which was set to begin Monday in the Philadelphia County Court of Common Pleas, was delayed due to a motion alleging an improper meeting between a plaintiff's doctor and a sales representative of the defense.
A Philadelphia couple whose minor daughter suffered birth defects allegedly as a result of medical malpractice has asked to discontinue their case against the physician and hospital system involved.
JACKSON, Miss. – Plaintiff attorneys from the most recently-decided bellwether case in the federal multi-district litigation surrounding blood thinner drug Xarelto have filed a motion seeking a retrial, believing newly-released medical evidence contradicted the case's courtroom testimony and would have swayed the jury to find for their clients.
PHILADELPHIA – A pair of plaintiffs claim Fiat Chrysler Automobiles violated federal and state laws when it sold them a new Dodge vehicle they believe was rife with mechanical issues.
JACKSON, Miss. – For a third consecutive time, a federal court jury has declared the manufacturers of Xarelto are not liable for medical injuries allegedly resulting from a plaintiff being prescribed the blood-thinner drug.
JACKSON – The third federal bellwether case revolving around blood-thinning drug Xarelto has begun; one which sees the claims of a Mississippi woman who was prescribed the blood-thinner drug for treatment of a blood clot, then allegedly suffered internal bleeding and anemia, go to trial.
NEW ORLEANS – The manufacturers of blood-thinner drug Xarelto have prevailed in the first federal bellwether trial to determine whether they were responsible for failing to provide a patient's prescribing physician with adequate instructions for the drug's safe use.
NEW ORLEANS – In the first week of the first federal bellwether trial connected to Xarelto, the former commissioner of the Food & Drug Administration (FDA) testified to his belief that the manufacturers of Xarelto misled patients on potential risks associated with the blood-thinning medication.
NEW ORLEANS – The initial bellwether trial to ascertain whether the manufacturers of Xarelto are liable for claims which allege the blood-thinning medication caused injury or death to more than 15,000 patients was slated to begin Monday in a Louisiana federal court.
PHILADELPHIA – Counsel for one in a group of companies who are accused of manufacturing a faulty natural gas system for a trash truck which exploded and left a man with third-degree burns have moved to dismiss claims against them for punitive damages.
